We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Characterization and Quantitation of Genotoxic Impurities Using a Single Platform – The Valsartan Case

Webinar

 
Characterization and Quantitation of Genotoxic Impurities Using a Single Platform – The Valsartan Case
 

Who's speaking at this Webinar?

Rolf Kern
Technical Marketing Manager, SCIEX
 

This webinar highlights key challenges related to the recent U.S Food and Drug Administration (FDA) recall of several medicines containing Valsartan, following the detection of genotoxic impurities. 
Rolf Kern from SCIEX will outline the current situation, explore the analytical methods used to characterize and quantify the impurities, and present a case study describing appropriate LC-MS methodology. 

Attend this webinar:
- For insight into the current market situation with regards valsartan recall
- To discover what the analytical method landscape looks like
- To learn how an LC-QTOF based method can be used for both characterization and quantification    of valsartan genotoxic impurities.

 
 
 
 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE